Study flags low rabies titres in many imported dogs: full analysis

A new signal in imported-dog surveillance is raising familiar questions about how much confidence veterinarians can place in rabies paperwork alone. A University of Guelph-led study, amplified by Scott Weese in Worms & Germs Blog, found that 48% of 67 dogs imported into Ontario had rabies antibody titres below 0.5 IU/mL, the benchmark widely used in international movement rules to show an adequate serologic response after vaccination. Nineteen percent of all imported dogs in the sample had titres below 0.1 IU/mL, meaning no measurable titre was detected. (wormsandgermsblog.com)

The concern isn't new, but the data sharpen it. Ontario has already dealt with imported canine rabies cases, including a 2021 dog brought in from Iran that later developed rabies despite meeting federal vaccination documentation requirements at entry. That case, and another imported rabid dog identified in Ontario in early 2022, helped drive Canada’s 2022 policy change prohibiting commercial dogs from countries at high risk for dog rabies. In other words, this latest titre study lands in a policy environment already shaped by real-world failures of document-based import controls. (pmc.ncbi.nlm.nih.gov)

The Ontario study compared imported dogs with dogs in Ontario that had rabies serology performed for other reasons. As summarized in Worms & Germs, only 8% of Ontario dogs tested for export purposes had titres below 0.5 IU/mL, versus 48% of imported dogs. The study authors noted that imported dogs had been sampled after arrival and before any rabies revaccination in Canada. The findings don't prove every low-titre dog was unprotected, because there is no absolute protective titre for an individual dog, but they do suggest that vaccination records from some source populations may overstate actual immune response. (wormsandgermsblog.com)

The broader importation picture also matters. A 2026 Veterinary Record review on European dog imports to the UK framed imported dogs as potential “reservoir dogs” for zoonotic and non-endemic pathogens, arguing that current controls focus too narrowly on rabies virus and Echinococcus multilocularis. UK authorities have separately tightened controls around Brucella canis, including mandatory pre-import testing for commercial dog imports from Romania beginning October 7, 2025, after reporting a steady rise in cases in Great Britain since 2020. That wider context reinforces a One Health point: rabies may be the headline risk, but it often isn't the only one. (eurekamag.com)

In North America, regulators have also moved toward tighter oversight. Congress’s January 2025 summary of the CDC dog import rule noted that the updated U.S. framework took effect August 1, 2024, requires all dogs entering the U.S. to be at least 6 months old, healthy on arrival, and accompanied by a CDC Dog Import Form, with added requirements for dogs vaccinated abroad or arriving from high-risk countries, including microchipping, endorsed vaccination records, rabies serology, or quarantine. The rule followed CDC concerns about falsified rabies vaccination documentation and the risk that a single imported rabid dog could reintroduce dog-maintained rabies virus variant. (congress.gov)

For veterinary professionals, the practical takeaway is less about panic and more about process. Recently imported dogs, especially rescue dogs, may warrant a more structured intake workflow: confirm country of origin and travel history, review vaccine records critically, ask whether any pre-export titre testing was performed, consider other import-associated pathogens, and make sure pet parents understand local revaccination and public health requirements. Ontario’s own guidance has emphasized revaccination of imported dogs with a vaccine approved in Canada, and Weese’s commentary points to newly imported dogs as an important touchpoint for veterinary review shortly after arrival. (wormsandgermsblog.com)

Why it matters: Low rabies titres in imported dogs don't automatically mean those dogs are incubating rabies, but they do expose a weak link in import risk management: compliance on paper doesn't always translate to dependable immunity. For clinics, shelters, and rescue partners, that has implications for staff safety, exposure response, client communication, and how imported dogs are triaged medically. It also supports a broader surveillance mindset, because the same channels that move dogs with questionable rabies protection can also move dogs carrying Brucella canis, leishmaniasis, echinococcosis, or exotic vectors. (pmc.ncbi.nlm.nih.gov)

What to watch: The next question is whether these data remain mainly a caution for frontline veterinarians, or whether they help push regulators toward more standardized post-import assessment, wider use of serology for selected dogs, or broader pathogen screening requirements tied to rescue and commercial importation. (pmc.ncbi.nlm.nih.gov)